NASDAQ: FATE · Biotechnology
Over the past week, Fate Therapeutics (FATE) saw 16 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 15% bullish but is deeply split: News runs 33% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 5 of 11 analysts rating FATE a buy.
There is little buzz around FATE this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 45% buy share sits next to a crowd that ranges from Reddit at 0% to News at 33%. No other tracker puts the two side by side.
Across 11 analysts the consensus is a Hold: 5 buy calls against 0 sell, with an average 12-month price target of $5.74.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 30 points above the crowd average of 15%, the professionals are more constructive than retail. The split is inside the crowd: News reads 33% bullish while Reddit sits at 0%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Fate Therapeutics (FATE) buzz held subdued around 22.2 while the price drifted down 5.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.6M shares. Updated Oct 10, 2026. Over the last 7 trading days, FATE lost 5.2%. Buzz activity in the recent week averaged 26.4 and was variable, swinging between 19.1 and 44.4. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 3 of the 11 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for FATE and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live FATE sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (5 / 6 / 0) |
| Crowd bullish (7d) | 15% |
| Avg price target | $5.74 |
| Most bullish source | News, 33% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 16 |
| Market cap | $255.2M |
| EPS · Beta | -$1.05 · 2.5 |
| Revenue (TTM) | $6.5M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Fate Therapeutics (FATE) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 15% bullish across 3 active sources. Those sources contribute 16 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Fate Therapeutics (FATE) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Fate Therapeutics (FATE), averaging 15% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 33% bullish and Reddit at 0%, a 33-point spread. On the professional side, 5 of 11 analysts rate FATE a buy.
Of the 11 analysts covering Fate Therapeutics (FATE), 5 rate it a buy, 6 a hold and 0 a sell, for a hold consensus. The average price target is $5.74. That puts the street ahead of the crowd, which averages 15% bullish.
Fate Therapeutics (FATE)'s cross-source average is bearish at 15% bullish. All 3 tracked sources lean bearish. X reads 11% bullish, News reads 33% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Fate Therapeutics (FATE) at 15% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 9 mentions (56% of total volume). Reddit contributes 4 mentions and News contributes 3 mentions. The cross-source average is bearish at 15% bullish, while x is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. FATE's sell signal at 93/100 conviction reflects a bearish cross-source average at 15% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The FATE sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key